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Abstract
Background: Appetite is affected by many factors including the hormones leptin, ghrelin and
adiponectin. Ghrelin stimulates hunger, leptin promotes satiety, and adiponectin affects insulin
response. This study was designed to test whether the pre- and postprandial response of key
appetite hormones differs in normal weight (NW) and severely obese (SO) women.
Methods: Twenty three women ages 25–50 were recruited for this study including 10 NW (BMI
= 23.1 ± 1.3 kg/m2) and 13 SO (BMI = 44.5 ± 7.1 kg/m2). The study was conducted in a hospital-
based clinical research centre. Following a 12-hour fast, participants had a baseline blood draw,
consumed a moderately high carbohydrate meal (60% carbohydrate, 20% protein, 20% fat) based
on body weight. Postprandially, participants had six blood samples drawn at 0, 15, 30, 60, 90, and
120 minutes. Primary measures included pre- and post-prandial total ghrelin, leptin, adiponectin and
insulin. A repeated measures general linear model was used to evaluate the hormone changes by
group and time (significance p ≤ 0.05).
Results: There were significant differences between the NW and the SO for all hormones in the
preprandial fasting state. The postprandial responses between the SO versus NW revealed: higher
leptin (p < 0.0001), lower adiponectin (p = 0.04), trend for lower ghrelin (p = 0.06) and insulin was
not different (p = 0.26). Postprandial responses over time between the SO versus NW: higher
leptin (p < 0.001), lower ghrelin and adiponectin (p = 0.004, p = 0.015, respectively), and trend for
higher insulin (p = 0.06).
Conclusion: This study indicates that significant differences in both pre- and selected post-
prandial levels of leptin, ghrelin, adiponectin and insulin exist between NW and SO women.
Improving our understanding of the biochemical mechanisms accounting for these differences in
appetite hormones among individuals with varying body size and adiposity should aid in the
development of future therapies to prevent and treat obesity.
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Background
The increasing prevalence of obesity [1-3] and subsequent
obesity-related health disorders [4,5] and mortality [6,7]
support the need for improved understanding of the etiol-
ogy of obesity which can provide insight to promote new
and effective prevention and treatment options. One
important research target is appetite, a key factor influenc-
ing energy intake and regulation.
As a processing centre for appetite, the hypothalamus
integrates signals from the brain, the peripheral circula-
tion and the gastrointestinal tract to regulate energy intake
and expenditure [8-11]. Within the hypothalamus, the
arcuate nucleus contains peptide neurotransmitters asso-
ciated with appetite [12]. Neuropeptide Y (NPY) and
agouti-related peptide (AGRP) are orexigenic (induce
feeding), whereas propiomelanocortin (POMC) and
cocaine- and amphetamine-regulated transcript (CART)
are anorexigenic (inhibit feeding) [11,13]. Neurons
expressing these neuropeptides communicate with each
other and with many peripheral signals including mech-
ano- and chemo-receptors, nutrients such as glucose,
amino acids and fatty acids, GI peptide hormones (i.e.,
cholecystokinin and ghrelin), and other hormones
including insulin, leptin, and adiponectin to influence
appetite level and feeding [14]. This study was designed to
further explore specific appetite hormones (leptin, ghre-
lin, adiponectin and insulin) following a moderately high
carbohydrate meal (60% carbohydrate, 20% protein, 20%
fat) administered to normal weight (NW) and severely
obese (SO) adult women 25–50 years of age.
This study builds upon previous adipocytokine/metabolic
meal response studies by comparing two groups of
women with a wide variation in body mass index (BMI).
This included NW (BMI 18.5 to < 25 kg/m2) and SO (BMI
40–49 kg/m2) which is classified as stage III obesity. We
hypothesized that there would be significant differences
in selected appetite hormones (ghrelin, leptin, adiponec-
tin and insulin) between NW and SO women in both the
fasting pre-prandial state, and in the post-prandial state
(0, 15, 30, 60, 90, 120 minutes); based on a group × time
interaction effect. A secondary study aim was to evaluate
if insulin or glucose levels correlated with leptin or ghrelin
levels pre- and post-prandially.
Methods
This study was conducted at the General Clinical Research
Centre (GCRC) in the University of Utah Medical Centre
Hospital (Salt Lake City, UT). The protocol was approved
by the University of Utah IRB and the GCRC review board.
All subjects signed an informed consent prior to participa-
tion. Exclusion criteria included pregnancy, recent weight-
loss or participation in any dieting behaviour in the past
six months, medications, smoking, menopause, and diag-
noses of cancer in the past five years. The NW participants
were recruited through sign postings and public radio
advertisements. The SO participants were recruited from a
database of individuals participating in an ongoing study
of gastric bypass surgery conducted by the University of
Utah Cardiovascular Genetics Division [15]. Ten women
with a BMI of 21–24 kg/m2 met the inclusion criteria for
the NW group and consented to participate. Thirteen
women met the inclusion criteria for the SO group with a
BMI of 40–49 kg/m2 (Stage III obesity) and consented to
participate.
The NW participants were required to arrive for testing by
7:30 A.M. The SO subjects, already participating a separate
obesity study [15] stayed overnight at the GCRC and
began the study at the same time in the morning as the
NW participants. All participants fasted for 12 hours and
abstained from exercise and drinking alcohol for 24 hours
prior to their visit. Height was measured using a Height-
Rite Seca stadiometer (Model 225) to the nearest cm.
Weight was measured using a Scaletronix scale to the near-
est 0.1 kg. An RJL Systems Quantum II was used to meas-
ure body composition via bioelectrical impedance (BIA).
Subjects completed a 61-item Willett food frequency
questionnaire, and a 7-item physical activity question-
naire.
The study breakfast contained approximately one-quarter
of the subjects kilocalorie (Kcal) needs estimated by the
Harris-Benedict equation [16] adjusted body weight
[(actual weight – ideal body weight) × 0.25]. The calcula-
tion and preparation of all meals was directed by the
GCRC head Registered Dietitian (RD). The breakfast com-
position, as a percent of totals Kcals was 60% carbohy-
drate, 20% protein and 20% fat and contained the same
food components for all participants with only the
amounts varying depending on their Kcal needs (Addi-
tional file 1). Participants were asked to consume the
entire meal. Any remaining food was weighed and quan-
tified by the GCRC RD. The clinic protocol and timing are
summarized in Additional file 2.
Blood measures included a fasting pre-prandial venous
blood sample and six postprandial samples taken during
a two-hour period following the ingestion of a breakfast
meal (0, 15. 30, 60, 90 and 120 minutes). These blood
samples were analyzed to evaluate changes in the levels of
insulin, total ghrelin, leptin, and adiponectin. At each of
the blood draws, 2 × 7 ml tubes of blood (1 serum, 1
EDTA) were used. The analysis of total ghrelin, leptin, and
adiponectin were done in duplicate using RIA kits (Linco
Research Inc., St. Charles, MO). Insulin was measured by
an RIA kit (Coat-A-Count, DPC, Los Angeles, CA). Addi-
tionally, glucose was measured enzymatically using stand-
ard procedures. The samples were analyzed by ARUPNutrition & Metabolism 2009, 6:32 http://www.nutritionandmetabolism.com/content/6/1/32
Page 3 of 8
(page number not for citation purposes)
(University of Utah Medical Centre Clinical Chemistry
Lab, Salt Lake City, Utah).
Statistical Methods
Descriptive statistics were run on all measures and results
are listed as mean ± standard deviation. The primary
dependent variables in this study included the hormones
insulin, leptin, total ghrelin, and adiponectin. The inde-
pendent variable was the study group (NW or SO). Anal-
ysis of covariance was used to test for baseline group
differences in each of the hormones while controlling for
age. Paired t-tests were used to determine changes from
baseline across time for each individual hormone. A
repeated measures general linear model was fit to the data
to test for mean differences in hormone levels between
groups across time. It was also used to test for dietary
response differences between groups by including an
interaction term between the NW and the SO ground and
the various time points for the hormone measurements.
To evaluate our secondary aims, Pearson correlations were
used to determine if insulin or glucose levels were corre-
lated with leptin or ghrelin levels at all time points meas-
ured. All statistics were computed with SPSS version 13
computer software (Chicago, IL). Significance was set at p
≤ 0.05.
Results
Physical characteristics of all participants are listed in
Additional file 3. Participants by group were similar in age
and height, but as expected, based on the BMI inclusion
criteria, their % body fat, and waist- and hip- circumfer-
ence were significantly different. All participants com-
pleted the entire meal, with the exception of four SO and
one NW participants. After accounting for returned food,
caloric intake range was 567.1 to 803.8 Kcals (mean 720.8
± 77.4 Kcals) in the NW group and 101.2 to 706.2 Kcals
(mean 588.5 ± 176.1 Kcals) in the SO group. Kilocalorie
intake was significantly less in the SO women than in the
NW women (p = 0.038).
As hypothesized, controlling for age, there were signifi-
cant differences between the NW and SO groups for base-
line leptin, ghrelin and adiponectin levels. Baseline leptin
levels were significantly higher in the SO group (48.1 ±
16.2 ng/ml) than in the NW group (10.1 ± 4.5 ng/ml) (p
< 0.001); baseline ghrelin levels were significantly higher
in the NW group (1418 ± 232 pg/ml) than in the SO
group (1087 ± 187 pg/ml) (p = 0.001); and baseline adi-
ponectin levels were significantly higher in the NW group
(12.8 ± 0.6 ng/ml) than in the SO group (10.7 ± 1.7 ng/
ml) (p < 0.001). Although baseline insulin levels were
higher in the SO group (11.4 ± 6.3 μU/ml) than in the NW
group (6.5 ± 8.7 μU/ml), when controlling for age these
differences were not significant (p = 0.18).
It was hypothesized postprandial leptin would not change
in the SO group, but would decrease in the NW group.
Postprandially, leptin levels in the NW women decreased
slowly, but this change did not reach significance until
120 minutes following the meal (p = 0.048 versus base-
line) (Figure 1). However, in the SO women, leptin levels
dropped much more dramatically than in their NW coun-
terparts (Figure 1). These decreases were significant at 15
(p = 0.034), 60 (p = 0.019), 90 (p = 0.004) and 120 min
(p = 0.002) postprandially. Compared to baseline, there
was a significant group × time interaction effect for leptin
postprandial responses (p < 0.001), indicating that leptin
decreased more over time in the SO compared to the NW
women. Averaged over time, the SO participants had a sig-
nificantly higher postprandial leptin levels than the NW
participants (p < 0.001). Paired student's T-tests revealed
the difference between groups was significant at all meas-
ured time points (p < 0.001).
We hypothesized that postprandial levels of ghrelin
would decrease immediately in both groups and then
increase. In the NW group, ghrelin levels decreased until
30 minutes post-meal (Figure 2). Levels began to increase
at the 60-minute time point, but remained below the
baseline level. Between 60 and 120 minutes following the
meal, ghrelin levels became significantly higher than base-
line. Compared with baseline, these changes were signifi-
cant at 30 (p < 0.001), 60 (p = 0.02), 90 (p = 0.008) and
120 minutes (p = 0.002).
Ghrelin levels in the SO group decreased insignificantly
from baseline until 30 minutes following the meal, then
Mean leptin levels (ng/ml) in 10 normal weight (solid line)  versus 13 severely obese (broken line) participants Figure 1
Mean leptin levels (ng/ml) in 10 normal weight (solid 
line) versus 13 severely obese (broken line) partici-
pants. The leptin response postprandially was significantly 
different between groups (p < 0.001), and averaged over 
time. Also, the severely obese participants had significantly 
higher *(p < 0.001) leptin levels than the normal weight par-
ticipants at all measured time points.
*
* *
* *
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increased dramatically through 120 minutes (Figure 2).
The increases reached significance at the 90- and 120-
minute time-points (p  < 0.001, for both). The ghrelin
response to a meal was quadratic, and showed a trend for
different response patterns between groups (p = 0.062).
Averaged over time, the NW group had a significantly
greater ghrelin response than the SO group (p = 0.004).
Paired student's T-tests showed ghrelin levels significantly
higher in NW women at baseline (p = 0.001), 15 (p =
0.001), 60 (p = 0.032) and 120 (p = 0.044) minutes post-
meal compared to SO women.
In both groups, adiponectin levels decreased slightly 15
minutes postprandially and remained below baseline lev-
els throughout the duration of the study (Figure 3).
Although these changes were small, in the NW group they
were significantly lower than baseline at 15 (p = 0.006),
60 (p = 0.035), 90 (p = 0.009) and 120 min (p = 0.003)
following the meal. The postprandial drop in adiponectin
levels in the SO group was not significant at any of the
time points. The postprandial response was significantly
different between groups (p = 0.040), and averaged over
time, the adiponectin levels were significantly higher in
the NW than in the SO women (p = 0.015). Paired stu-
dent's T- tests found that these levels were significantly
higher in NW women at baseline (p = 0.001), 15 (p =
0.018), 30 (p = 0.021), and 60 (p = 0.040) minutes post-
prandially.
Insulin levels increased dramatically following the meal,
and slowly decreased through 120 minutes, but did not
return to baseline levels in either group (Figure 4). In the
NW and SO groups, respectively, these changes were sig-
nificantly different from baseline at 15 (p < 0.001 for both
groups), 30 (p < 0.001 for both groups), 60 (p < 0.001 and
p = 0.001), 90 (p < 0.001 and p = 0.002) and 120 minutes
(p = 0.002 and p = 0.013). As with the other hormones, we
Mean ghrelin levels (pg/ml) in 10 normal weight (solid line)  versus 13 severely obese (broken line) women Figure 2
Mean ghrelin levels (pg/ml) in 10 normal weight 
(solid line) versus 13 severely obese (broken line) 
women. The ghrelin response postprandially showed a 
trend for a difference between groups (p = 0.06). Averaged 
over time, the normal weight group had significantly higher 
postprandial ghrelin levels than the severely obese group (p = 
0.004). Ghrelin levels were significantly higher * (p ≤ 0.05) in 
normal weight women at baseline (p = 0.001), 15 (p = 0.001), 
60 (p = 0.032) and 120 (p = 0.044) minutes postprandially.
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Mean adiponectin levels (ng/ml) in 10 normal weight (solid  line) versus 13 severely obese (broken line) women Figure 3
Mean adiponectin levels (ng/ml) in 10 normal weight 
(solid line) versus 13 severely obese (broken line) 
women. The postprandial response was significantly differ-
ent between groups (p = 0.040), and averaged over time, the 
adiponectin level was significantly higher in the normal weight 
than in the severely obese (p = 0.015). These levels were sig-
nificantly higher * (p ≤ 0.05) in normal weight women at 
baseline (p = 0.001), 15 (p = 0.018), 30 (p = 0.021), and 60 (p 
= 0.040) minutes.
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Mean insulin levels (μU/ml) in 10 normal weight (solid line)  versus 13 severely obese (broken line) participants Figure 4
Mean insulin levels (μU/ml) in 10 normal weight 
(solid line) versus 13 severely obese (broken line) 
participants. The postprandial response was not signifi-
cantly different between groups (p = 0.260), but averaged 
over time, insulin levels showed a trend to be higher in the 
severely obese group than in the normal weight group (p = 
0.064). Insulin levels were significantly higher * (p < 0.05) in 
the severely obese group only at 15 minutes postprandially 
(p = 0.025).
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hypothesized there would be a significant group × time
interaction effect with insulin. However, the postprandial
response was not significantly different between groups (p
= 0.26). Averaged over time, the mean insulin levels
showed a trend to be higher in the SO group than in the
NW group (p  = 0.06). Insulin levels were significantly
higher in the SO group than in the NW group only at 15
minutes postprandially (p = 0.025).
As a secondary aim, we evaluated the correlation of insu-
lin and glucose levels with leptin and ghrelin levels. There
was a significant correlation between insulin and leptin at
15 (r = 0.74, p = 0.015) and 30 (r = 0.67, p = 0.034) min-
utes postprandially in the NW women. In the SO women,
there were no significant correlations between insulin and
leptin at any of the time points measured. At 120 minutes
post-meal, there was a trend toward an inverse correlation
between insulin and ghrelin (r = -0.59, p = 0.07) in NW
women, but there were no significant correlations at any
of the other measured time points. Insulin and ghrelin
were not significantly correlated at any of the time points
measured in the SO women.
There was a significant inverse correlation in the SO group
between baseline glucose levels and leptin at baseline (r =
-0.59, p = 0.033), 30 (r = -0.62, p = 0.031), 60 (r = -0.66,
p = 0.019) and 90 (r = -0.71, p = 0.007) minutes postpran-
dially. Glucose was not significantly correlated with leptin
levels in the NW women at any time. There was a signifi-
cant inverse correlation between baseline glucose levels
and ghrelin in the NW group at 90 minutes following the
meal (r = -0.65, p = 0.043), but not at any other time
points in this group or at any of the time points in the SO
group.
Discussion
The purpose of this study was to test whether different adi-
pocytokine/metabolic responses to a meal exist among
NW and SO women. Similar to previous research, base-
line leptin levels were significantly greater in the SO group
than in the NW group [17-20]. Because leptin is made in
adipose tissue, the baseline difference between groups is
to be expected, but because leptin is a satiety factor, higher
levels would seem to cause a decrease in consumption,
rather than the increased caloric intake usually associated
with obesity. These results support the view that SO indi-
viduals most likely exhibit some sort of leptin resistance,
either due to decreased leptin transport into the brain, or
due to a down regulation of leptin receptors. Previous
studies, exploring biochemical interactions of leptin with
feeding and meal composition have shown leptin to
decrease following fasting and dieting [21,22], and to
increase in response to a carbohydrate versus a fat-rich
meal [17,23,24].
In this study which used a moderately high carbohydrate
meal, leptin levels decreased significantly in the SO
women throughout the two-hours measured but did not
change significantly in the NW women. These results dif-
fer from those reported by English, et al. [17] who
observed that leptin levels decreased in the NW individu-
als and did not change significantly in the SO individuals.
Results from our study more closely resemble the results
found by Imbeault, et al., who reported increased leptin
levels in NW men and decreased leptin levels in SO men
following a unusually high fat meal (64% fat, 18% carbo-
hydrate, and 18% protein), dramatically different from
the meal and population we used [25]. Moreover, it is
possible some the variation in results are due to adjusted
Kcal levels that were based on the subjects body weight
versus a single Kcal level for all participants. Because of the
different results found in these studies, future leptin
research should include a comparison of the response to
a high-carbohydrate meal vs. a high-fat meal, including
both NW and SO men and women.
Currently debate exists whether leptin levels are influ-
enced more by insulin secretion or glucose uptake. This
study demonstrated a significant correlation between
insulin and leptin at selected time points (15 and 30 min-
utes postprandially) in NW women, but no correlation
was reported at any time points in the SO women. Glu-
cose levels were only measured at baseline in this study,
but in the SO women there was a significant inverse cor-
relation between baseline glucose levels and leptin levels
at baseline 30, 60 and 90 minutes. Therefore, these results
do appear to support the view that glucose may be more
influential for leptin secretion than insulin in SO women.
Baseline ghrelin levels were significantly higher in the NW
women than in the SO women, supporting previous
research [17,18,26-30]. Ghrelin levels are an inverse indi-
cation of total energy balance and thus in SO individuals
who are constantly in a state of positive energy balance,
lower ghrelin levels are expected.
Baseline to 60 minutes following the meal, ghrelin levels
decreased significantly in the NW group, after which they
increased dramatically through 120 minutes. The SO
group followed the same pattern, but did not reach signif-
icance until 90 min postprandially. These results also sup-
port previous findings that the ghrelin response to a meal
is less pronounced in SO individuals than it is in NW indi-
viduals [17,21,27,31,32]. Our findings on the postpran-
dial rise in ghrelin are different from a recent study that
used a higher CHO meal (80%) and showed in NW and
overweight men and women (BMIs ranging from 19–29
kg/m2) that the postprandial decrease in ghrelin remained
below baseline levels for more than three hours, not
returning to baseline levels until four hours postprandi-Nutrition & Metabolism 2009, 6:32 http://www.nutritionandmetabolism.com/content/6/1/32
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ally[33]. Although ghrelin is better known for its effect on
appetite stimulation, the drop in ghrelin following food
intake is associated with satiety. Therefore, the less signif-
icant drop in ghrelin immediately postprandially in SO
individuals may account for decreased satiety leading to
increased intake over time in these individuals. This less
significant drop in ghrelin immediately postprandially
may have been influenced by the fact the total volume of
Kcals consumed by the SO (mean 588.5 ± 176.1 Kcals)
was significantly less (p = 0.038) as compared to the NW
group (mean 720.8 ± 77.4 Kcals).
With respect to the relationship of ghrelin to insulin and
glucose; there was a trend for an inverse correlation
between insulin and ghrelin (r = -0.59, p = 0.07) in the
NW group only and only at two hours postprandially.
This likely would have become statistically significant
with a larger sample size. Related to this there was a signif-
icant inverse correlation between baseline glucose levels
and ghrelin in the NW group at 90 minutes following the
meal (r = -0.65, p = 0.043). In contrast to these findings, a
recent study that included 29 normal weight and over-
weight males and females found no relationships between
ghrelin, insulin, and glucose parameters despite measure-
ments going out six hours postprandially [33].
Like leptin, adiponectin is also made in the adipose tissue,
but levels of this hormone were significantly lower in the
SO group than in the NW group. These results are consist-
ent with previous research [18,34-39], but continue to be
counterintuitive. Expression of the mRNA responsible for
the production of adiponectin is significantly decreased in
the adipose tissue of obese mice and humans, which may
explain why this occurs [35,40].
Following the meal, adiponectin levels decreased and
remained below baseline levels at all measurement
points. These changes were significant for the NW group,
but not for the SO group, probably due to a high level of
variability in the SO women. Similar results for the NW
group, but very different results in the SO group were
reported by English, et al. who used a similar dietary com-
position (56.8% carbohydrate, 12.2% protein, 31% fat)
[41]. In that study, adiponectin levels rose four-fold by 60
minutes postprandially in SO individuals. The authors
stated that adiponectin levels may have been affected by
interference with the assay due to "exaggerated postpran-
dial hypertriglyceridemia," but that it appears unlikely
this would specifically affect the obese group. Addition-
ally the postprandial peak in triglycerides generally occurs
later than 60 minutes. Postprandial triglyceride levels of
participants in the current study are not available, so we
are unable to determine if exaggerated postprandial
hypertriglyceridemia may have affected the results. Fur-
ther research in this area is needed to determine which
postprandial adiponectin profile should be expected in
SO individuals.
A strength of this study was that all participants were seen
in the GCRC for standardized study protocol administra-
tion. Also, the use of a body weight specific caloric load
was another study strength. Previous similar hormonal
feeding studies typically used a set meal size for all partic-
ipants in the study which has the potential of producing
alterations in hormonal responses and other blood meas-
ures (glucose) due to variations in the total substrate and
Kcal load in relation to body size. Estimating the caloric
needs of each participant in the current study using a
widely accepted formula (Harris Benedict) may have facil-
itated a closer matching of each participant's actual needs.
Related to this, meal size may also have represented a lim-
itation of this study since five participants did not finish
their meals (four from the SO group and one from the NW
group), which may have affected their hormone responses
since the overall Kcal intake was slightly lower in the SO
group. Based on appetite hormone levels differences by
group, this makes sense acutely, given the SO pre- and
post- prandial ghrelin levels were lower than the NW par-
ticipants. In addition, several participants who did finish
their meal reported the meal was larger than what they
would normally consume for breakfast. A measurement
limitation of this study was that our ghrelin measurement
only included total ghrelin and did not include plasma
acyl and desacyl ghrelin which have potential important
roles in the postprandial regulation of satiety [42]. Fur-
thermore, there are numerous other gut peptides that
influence energy intake that were not measured in this
study (eg. CCK, peptide YY, glucagon-like peptide-1, pan-
creatic polypeptide, and oxyntomodulin.) and other
parameters which could have helped in explaining the
results (e.g. blood lipids including triglycerides). Another
limitation of this study was sample size. Although similar
to the sample sizes of previous appetite hormone studies,
only moderate to large changes or differences could be
detected in the analyses of this study.
Conclusion
In conclusion, both the baseline levels (fasting pre-pran-
dial) and the postprandial response of hormones associ-
ated with appetite (ghrelin, adiponectin, and leptin) are
significantly different in NW and SO women. Few studies
to date have reported these responses in SO women. Since
appetite is a key factor related to body composition, the
hormonal differences following a meal as reported in this
study may be partially responsible for weight mainte-
nance, weight gain, or resistance to weight loss among
individuals represented by different BMI classifications
(i.e., NW versus SO). Further understanding of the bio-
chemical mechanisms accounting for pre- and post- pran-Nutrition & Metabolism 2009, 6:32 http://www.nutritionandmetabolism.com/content/6/1/32
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dial hormonal variation among individuals with various
body sizes and body compositions should aid in the
development of therapies to prevent and treat obesity.
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